Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06907147 · ClinicalTrials.gov registry record · NA

SPYRAL GEMINI Pilot Study

A NA study of Hypertension and Cardiovascular Diseases, sponsored by Medtronic Vascular.

Recruiting
Registry status
NA
Development phase
175
Enrollment target
13
Study locations

NCT06907147: Recruiting NA study of Hypertension and Cardiovascular Diseases, sponsored by Medtronic Vascular.

NCT06907147 is a NA study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Medtronic Vascular. The registered enrollment target is 175 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06907147, a NA study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Medtronic Vascular.

RECRUITING
Registry status
NA
Development phase
175 participants
Enrollment target
13
Study locations

Study Summary

The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

Interventions

  • DEVICE Multi-Organ Denervation Gemini System

Study Locations (13)

Other

  • Royal Perth Hospital (Dobney Hypertension Centre) - Perth
  • Hippokration General Hospital - Athens
  • University Hospital of Galway - Galway
  • University Hospital Basel - Basel

Texas

  • Baylor Heart & Vascular Hospital - Dallas
  • UT Health East Texas - Tyler

California

  • Stanford Hospital and Clinics - Stanford

Georgia

  • Piedmont Heart Institute - Atlanta

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Michigan

  • Henry Ford Providence Hospital - Southfield

Mississippi

  • North Mississippi Medical Center - Tupelo

Nevada

  • Renown Regional Medical Center - Reno

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2025-05-01
Est. Completion 2029-12-22
Phase NA
Medtronic Vascular

26 total trials

What NCT06907147 shows while recruiting

NCT06907147 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Multi-Organ Denervation Gemini System is the first listed.

NCT06907147 lists 13 locations in 9 states (Other, Texas, California).

Frequently Asked Questions

What is clinical trial NCT06907147 about?

NCT06907147 is a clinical study titled "SPYRAL GEMINI Pilot Study". The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

What is the current status of trial NCT06907147?

This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2025-05-01. Estimated completion is 2029-12-22.

What conditions does trial NCT06907147 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Diabetes Mellitus, Chronic Kidney Diseases, Vascular Diseases.

What interventions are being tested in trial NCT06907147?

The interventions under investigation include: Multi-Organ Denervation Gemini System (DEVICE).

Who is sponsoring clinical trial NCT06907147?

This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06907147 being conducted?

This trial has 13 study locations across California, Georgia, Massachusetts, Michigan, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06907147's enrollment target sits among peer trials

175 234th of 470 higher than 236 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04722341 · 175 participants · NA

    Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  • NCT05094037 · 175 participants · NA

    Orthotic Treatment of Diabetic Foot Ulcers

  • NCT05165745 · 175 participants · NA

    Stick2PrEP Cisgender Women and Trans Individuals

  • NCT05312255 · 175 participants · NA

    Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06907147, the US trial registry maintained by the National Library of Medicine. NCT06907147 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.